AI Terminal
MPH Health Care
Earnings Release • Nov 30, 2015
5425_rns_2015-11-30_62c21586-90c1-4cd4-af40-a38d467b86a0.html
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 30 November 2015 08:00
MPH Mittelständische Pharma Holding AG: Positive business performance in the first 9 months of 2015
DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): 9-month figures/Quarter Results
2015-11-30 / 08:00
The issuer is solely responsible for the content of this announcement.
MPH Mittelständische Pharma Holding AG:
Positive business performance in the first 9 months of 2015
In the first 9 months of 2015 MPH Group achieved sales to the amount of 178.6 million Euro (previous year’s period: 163.8 million Euro). The profit for the period totalled 4.0 million Euro. The affiliated companies of MPH AG could further expand their position in the healthcare market.
The performance of the shareholdings was very positive. The listed investments in HAEMATO, M1 and CR Capital valued at 133.5 million Euro as of 30.09.2015. Compared to the previous quarter the entire intrinsic value of the MPH AG increased by 16 % and totalled 134.6 million Euro as of 30.09.2015. This corresponds to 3.14 Euro per share.
We are very pleased with the performance of our investments.
This argues for our valuable investment strategy and gives us confidence for the whole year 2015″, say Patrick Brenske and Dr Christian Pahl, Members of the Management Board of MPH AG about the 9-months figures.
About MPH Mittelständische Pharma Holding AG:
The Berlin based MPH Mittelständische Pharma Holding AG invests mainly in companies acting in the healthcare market.
The shareholding HAEMATO AG contributes to cost reductions in the healthcare systems with medicines on the basis of patent-free and patent-protected active substances for therapies of chronic diseases.
M1 Beauty AG offers patient-individual services, aesthetic surgeries and medical treatments.
The MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) on the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
Contact: Frau Linda Reichelt
MPH Mittelständische Pharma Holding AG
Grünauer Straße 5
D-12557 Berlin
Phone: +49 (0) 30 897308660 Fax: +49 (0) 30 897308669
E-Mail: [email protected] Web: www.mph-ag.de
2015-11-30 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MPH Mittelständische Pharma Holding AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | 030 / 897 308 660 |
| Fax: | 030 / 897 308 669 |
| E-mail: | [email protected] |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A0L1H32 |
| WKN: | A0L1H3 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt |
| End of News | DGAP News Service |